ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
The role of rivaroxaban in left ventricular thrombi [Anatol J Cardiol]
Anatol J Cardiol. 2019; 21(1): 47-50 | DOI: 10.14744/AnatolJCardiol.2018.48313

The role of rivaroxaban in left ventricular thrombi

Mahmoud Abdelnaby1, Abdallah Almaghraby2, Ola Abdelkarim2, Yehia Saleh3, Basma Hammad4, Haitham Badran5
1Cardiology and Angiology Unit, Department of Clinical and Experimental Internal Medicine, Medical Research Institute, University of Alexandria; Alexandria-Egypt
2Department of Cardiology, Faculty of Medicine, University of Alexandria; Alexandria-Egypt
3Department of Internal Medicine, Michigan State University; East Lansing, Michigan-United States of America
4Department of Cardiology, Massachusetts General Hospital; Boston-United States of America
5Department of Cardiology, Ain Shams University; Cairo-Egypt

Keywords: Left ventricular apical thrombi, Novel Oral Anticoagulants (NOACs), Rivaroxaban, Vitamin K Antagonist (VKA), Acute Coronary Syndromes (ACS), Dual Antiplatelet Therapy (DAPT)

Mahmoud Abdelnaby, Abdallah Almaghraby, Ola Abdelkarim, Yehia Saleh, Basma Hammad, Haitham Badran. The role of rivaroxaban in left ventricular thrombi. Anatol J Cardiol. 2019; 21(1): 47-50

Corresponding Author: Abdallah Almaghraby, Egypt
Manuscript Language: English

Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2024 The Anatolian Journal of Cardiology

Kare Publishing is a subsidiary of Kare Media.